feed icon rss

Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
Filter
  • Online-Ressource  (9)
  • 2010-2014  (9)
  • Dhalla, Naranjan S.  (9)
Medientyp
  • Online-Ressource  (9)
Sprache
Region
Bibliothek
Erscheinungszeitraum
Jahr
Fachgebiete(RVK)
Schlagwörter
Zugriff
  • 1
    Online-Ressource
    Online-Ressource
    New York, NY : Springer
    UID:
    gbv_1652147128
    Umfang: Online-Ressource (XI, 569 p. 80 illus., 48 illus. in color, digital)
    ISBN: 9781461459309
    Serie: Advances in Biochemistry in Health and Disease 5
    Weitere Ausg.: ISBN 9781461459293
    Weitere Ausg.: Buchausg. u.d.T. ISBN 978-1-461-45929-3
    Sprache: Englisch
    URL: Cover
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 2
    Online-Ressource
    Online-Ressource
    New York, NY : Springer
    UID:
    gbv_1652259856
    Umfang: Online-Ressource (XVIII, 532 p. 66 illus., 52 illus. in color, digital)
    ISBN: 9781461458579
    Serie: Advances in Biochemistry in Health and Disease 6
    Inhalt: Angiogenesis plays a key role in human physiology and pathophysiology. While necessary for tissue growth and development, uncontrolled angiogenesis plays a role in the progression of certain tumors as well as atherosclerosis. Lack of angiogenesis may be the basis of myocardial ischemia and stroke. Knowledge on the mechanisms of angiogenesis is growing very rapidly, and may lead to important drugs for therapy of a variety of clinical disorders. Experts from around the world have contributed a vast array of data on different aspects of angiogenesis in this volume edited by Professors Mehta and Dhalla. This information will be of immense help to basic scientists, clinicians and those involved in drug development
    Anmerkung: Description based upon print version of record , Biochemical Basis and Therapeutic Implications of Angiogenesis; Preface; Contents; Contributors; Part I:Molecular Mechanisms of Angiogenesis; Chapter 1: Endothelial Growth Factor Receptors in Angiogenesis; 1.1 Introduction: The Signaling Axes Behind Angiogenesis; 1.2 The VEGF Axis; 1.2.1 VEGF Structure and Function; 1.2.1.1 The VEGF Receptors; VEGFR-1; VEGFR-2; VEGFR-3; 1.3 Co-receptors; 1.4 The Role of the Endothelial Growth Factor Receptors in Angiogenesis and Neovascularization; 1.4.1 The Role of the Endothelial Growth Factor Receptors in Tumorigenesis; 1.4.1.1 VEGFR-1; 1.4.1.2 VEGFR-2 , 1.4.1.3 VEGFR-31.4.1.4 Prognosis; 1.4.1.5 Metastasis; 1.4.1.6 Autocrine Signaling; 1.4.1.7 Therapeutic Applications; 1.4.2 The Eye; 1.4.2.1 Therapeutic Applications; 1.4.3 Pro-angiogenic Therapies; 1.5 Conclusion; References; Chapter 2: Role of Transforming Growth Factor Beta in Angiogenesis; 2.1 TGFb Molecule Family: Sources, Activation, and Regulation of Transcription; 2.1.1 The TGFb Family; 2.1.2 TGFb Sources; 2.1.3 Synthesis and Activation of TGFb; 2.1.4 Regulation of Transcription by TGFb; 2.1.5 TGFb's Role in Angiogenesis; 2.2 TGFb Receptors and Signaling; 2.2.1 Canonical Smad Signaling , 2.2.2 Noncanonical Signaling Pathways2.2.2.1 MAPK; 2.2.2.2 Rho-GTPase; 2.2.2.3 PI3K (AKT); 2.3 TGFb and Endothelial Sprouting, Proliferation, and Permeability; 2.3.1 Endothelial Sprouting; 2.3.2 Endothelial Permeability; 2.3.3 Endothelial Proliferation and Migration; 2.4 TGFb Co-receptors in Angiogenesis; 2.4.1 Regulation of TGFb Ligand Access to Co-receptors; 2.5 TGFb and Vascular Mural Cells; 2.6 Pathological Angiogenesis; 2.6.1 HHT; 2.6.2 Organ Fibrosis; 2.6.3 Cancer; 2.7 Conclusion; References; Chapter 3: Role of Cytokines in Angiogenesis: Turning It On and Off; 3.1 Introduction , 3.2 The Sequential Steps of Angiogenesis: Vessel Branching, Maturation, and Quiescence3.3 The Players; 3.4 VEGF; 3.5 Notch; 3.6 FGF; 3.7 Ephrin and Ephrin Receptors; 3.8 TGF-b; 3.9 Platelet-Derived Growth Factor; 3.10 Angiopoietins and Tie Receptors; 3.11 Chemokines and G Protein-Coupled Receptors; 3.12 Inhibitors of Angiogenesis; 3.13 Cytokines in Tumor Angiogenesis; 3.14 Conclusion; References; Chapter 4: Neuropeptides and Angiogenesis; 4.1 Introduction; 4.2 Neuropeptide Y; 4.3 NPY and Angiogenesis; 4.4 Substance P; 4.5 SP and Angiogenesis; 4.6 Calcitonin Gene-Related Peptide , 4.7 CGRP and Angiogenesis4.8 Vasoactive Intestinal Peptide; 4.9 VIP and Angiogenesis; 4.10 Somatostatin; 4.11 Somatostatin and Angiogenesis; 4.12 Conclusions; References; Chapter 5: Role of Integrins in Angiogenesis; 5.1 Introduction; 5.2 Bidirectional Signaling by Integrins Regulates Cellular Fate; 5.3 Integrin Binding to Proteolytic Protein Fragments; 5.4 Cross talk of Integrins with Other Signaling Pathways; 5.4.1 Notch Signaling; 5.4.2 VEGF Signaling; 5.4.3 TGF-b Signaling; 5.5 Integrin Inhibition in Tumor Angiogenesis; 5.6 Integrin Inhibitors in Clinical Development; 5.6.1 Cilengitide , 5.6.2 ATN-161 , Part A: Molecular Mechanisms of Angiogenesis -- Endothelial Growth Factor Receptors in Angiogenesis -- Role of Transforming Growth Factor Beta in Angiogenesis -- Role of Cytokines in Angiogenesis: Turning it On and Off -- Neuropeptides in Angiogenesis -- The Role of Integrins in Angiogenesis -- Regulation of Angiogenesis by Hypoxia-inducible Factors -- Role of Mast Cells in Angiogenesis -- Vascular Stem Cells in Regulation of Angiogenesis -- Toll-like Receptor-linked Signal Transduction in Angiogenesis -- The Role of Sex Steroids in Angiogenesis -- Biochemical Mechanisms of Exercise-induced Angiogenesis -- Part B: Pathophysiological Aspects of Angiogenesis -- Angiogenesis in Atherosclerosis: An Overview -- Role of Serotonin in Angiogenesis in Diabetes -- Brain Angiogenesis after Stroke -- Angiogenesis in Myocardial Ischemia -- Adipose Tissue-derived Mesenchymal Stem Cell and Angiogenesis in Ischemic Heart Disease -- Trials of Angiogenesis Therapy in Patients with ischemic Heart Disease -- Angiogenesis in Cancer -- Potential Mechanisms Linking Oxidized LDL to Susceptibility to Cancer -- Role of Genetic Polymorphisms in the Angiogenesis Pathway and Non-small Cell Lung Cancer Tumor Behavior -- Part C: Pharmacology and Therapy of Angiogenesis -- Angiogenesis and Arteriogenesis Factors: Their Role in the Treatment of Cancer and Arterial Regeneration -- Physiological Roles and Therapeutic Implications of Hepatocyte Growth Factor for Angiogenesis -- Harnessing Endothelial Progenitor Cells for Therapeutic Angiogenesis -- Microarray and MiRs in Angiogenesis -- MicroRNA and Cardiovascular Disorders, with a Focus on Angiogenesis -- An Overview of Angiogenesis Inhibitors from Natural Sources -- Index.
    Weitere Ausg.: ISBN 9781461458562
    Weitere Ausg.: Buchausg. u.d.T. ISBN 978-1-461-45856-2
    Sprache: Englisch
    URL: Volltext  (lizenzpflichtig)
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 3
    Online-Ressource
    Online-Ressource
    New York, NY : Springer New York
    UID:
    gbv_165312881X
    Umfang: Online-Ressource (XI, 462 p. 58 illus., 46 illus. in color, online resource)
    ISBN: 9781461490999
    Serie: Advances in Biochemistry in Health and Disease 8
    Inhalt: It is now well known that proteases are found everywhere, in viruses and bacteria as well as in all human, animal and plant cells, and play a role in a variety of biological functions ranging from digestion, fertilization, development to senescence and death. Under physiological conditions the ability of proteases is regulated by endogenous inhibitors. However, when the activity of proteases is not regulated appropriately, disease processes can result, as seen in Alzheimer’s disease, cancer metastasis and tumor progression, inflammation and atherosclerosis. Thus it is evident that there is an absolute need for a tighter control of proteolytic activities in different cells and tissues. Aimed at graduate students and researchers with an interest in cellular proteolytic events, Role of Proteases in Cellular Dysfunctions is the second book on Proteases in this series. The book consists of three parts in specified topics based on current literatures for a better understanding for the readers with respect to their subject-wise interests. The first section of this book covers a brief idea about the neuronal disorders and the involvement of proteases such as calpains, caspases and matrix metalloproteases (MMPs). The second section covers the deadly disease cancer and its relation to ubiquitin-proteosomal system, MMPs and serine proteases. The last section is about the role of proteases such as calpains, MMPs and serine protease as well as urokinase type plasminogen activator receptor (uPAR) in causing cardiovascular defects
    Anmerkung: Description based upon print version of record , Part A: Proteases and Neural Disorders.- Role of Calpain in Immunobiology of Neurodegenerative Diseases.- Calpain Interactions with the Protein Phosphatase Calcineurin in Neurodegeneration.- Involvement of Caspases in Neurodegenaration and Stroke.- Matrix Metalloproteinases in Ischemia-Reperfusion Injury in Brain: Antioxidants as Rescuer.- The Role of Matrix Metalloproteinases in Neurovascular Injury.- The Role of Proteases in Embryonic Neural Crest Cells.- Part B: Proteases and Cancer     Proteases and Cancer Development.- Matrix Metalloproteinase and its Inhibitors in Cancer Progression.- Ubiquitin-Proteosome System in the Hallmarks of Cancer.- Matrix Metalloproteinases in Cancer Metastasis: An unsolved Mystery.- A Disintegrin and Metalloprotease-12 as a New target for Cancer Treatment -- Proteases and Their Role in Drug Development with an Emphasis in Cancer.- Part C: Proteases and Cardiovascular Defects.- Role of Matrix Metalloproteinases in Atherosclerosis.- The Importance of the Urokinase-type Plasminogen Activator (uPA) and its receptor (uPAR) for the Development and Progression of Atherosclerosis.- Matrix Metalloproteinases and Hypertension.- Regulation of Proteolysis in Vascular Remodeling.- Emerging Role of Genetic Variants of Matrix Metalloproteinases Genes in Left Ventricular Dysfunction.- Implications of Intracellular Proteolytic Activation of MMP-2 in the Heart.- Matrix Metalloprotease-2 in the Development and Progression of Cardiovascular Diseases.- Role of Protease Activation in Subcellular Remodeling and Heart Failure.- Proteases as Potential Targets in Left Ventricular Remodeling After Myocardial Infarction.- MMPs in Cardiovascular Diseases: Emerging Pharmacological Targets.- Proteases as Clinical Markers of Adverse Remodeling for Heart Failure in the Aging Population.
    Weitere Ausg.: ISBN 9781461490982
    Weitere Ausg.: Druckausg. ISBN 978-146-149-098-2
    Sprache: Englisch
    URL: Volltext  (lizenzpflichtig)
    URL: Cover
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 4
    Online-Ressource
    Online-Ressource
    New York, NY : Springer New York
    UID:
    gbv_1654458422
    Umfang: Online-Ressource (XIX, 410 p. 69 illus., 53 illus. in color, online resource)
    ISBN: 9781493904648
    Serie: Advances in Biochemistry in Health and Disease 10
    Inhalt: Phospholipases generate lipid signaling molecules through their hydrolytic action on phospholipids and are known to regulate function of a variety of cells under normal and diseased conditions. While several physiological, biochemical and molecular techniques have identified key players involved in different disease processes, phospholipases have also emerged as critical players in the pathogenesis of a number of different diseases including cancer and heart disease. In addition, phospholipases are also implicated in such conditions as brain disorder/injury, kidney and immune cell dysfunction. Phospholipases in Health and Disease is a compilation of review articles dedicated to the study of the field with respect to biochemical and molecular mechanisms of normal and abnormal cell function. The wide range of area covered here is of interest to basic research scientists, clinicians and graduate students, who are engaged in studying pathophysiological basis of a variety of diseases. Furthermore, this book highlights the potential of the different phospholipases as therapeutic targets as well as part of prevention strategies. Twenty three articles in this book are organized in four sections that are designed to emphasize the most characterized forms of the phospholipases in mammalian cells. The first section discusses general aspect of phospholipases. Section two covers the role and function of phospholipase A in different pathophysiological conditions. The third section is focussed on phospholipase C which is believed to play a central role in transmembrane signaling. The final section covers phospholipase D which is present in a variety of different cells. The book illustrates that the activation of phospholipases is of fundamental importance in signal transduction affecting cell function. Overall, this book discusses the diverse mechanisms of phospholipase mediated signal transduction in different pathophysiological conditions and raises the possibility of specific forms of phospholipases serving as novel targets for drug development
    Anmerkung: Description based upon print version of record , Phospholipases in Health and DiseaseRole of Phospholipases in Regulation of Cardiolipin Biosynthesis and Remodelling in the Heart and Mammalian Cells -- Role of Phospholipases and Oxidized Phospholipids in Inflammation -- Phospholipases in Cardiovascular Disease -- The Structures and Functions of Intracellular Phospholipase A1 Family Proteins -- Phospholipase A and Breast Cancer -- Pathophysiological Aspects of Lipoprotein Associated Phospholipase A2: A Brief Overview -- Phospholipase A2 Activity Exhibited by a Bacterial Virulence Protein that Enters and Operates within a Variety of Host Cells -- Expression and Role of Phospholipase A2 in Central Nervous System Injury and Disease -- Cytoplasmic Phospholipase A2 and Autotaxin Inhibitors as Potential Radiosensitizers -- Phospholipase A2 Enzymes: Potential Targets for Therapy -- The Role of Phospholipase C Isozymes in Cellular Homeostasis -- Phospholipase C in the Immune Cell -- Phosphoinositide-specific Phospholipase C Enzymes and Cognitive Development  and Decline -- Where life begins: Sperm PLCz in mammalian egg activation and implications in male infertility -- Oocyte Activation and Phospholipase C zeta (PLCζ): Male Infertility and  Implications for Therapeutic Intervention -- Phospholipase C Signaling in Heart Disease -- Activation of Phospholipase C in Cardiac Hypertrophy -- The Protective Effect of Phospholipase C From Cardiac Ischemia-Reperfusion Injury -- Role of Phospholipase C in Cardioprotection During Oxidative Stress -- Mammalian Phospholipase D: Structure, Regulation and Physiological Functions of Phospholipase D and its Link to Pathology -- Emerging Roles of Phospholipase D in Pathophysiological Signaling -- Alterations in Phospholipase D During the Development of Myocardial Disease.
    Weitere Ausg.: ISBN 9781493904631
    Weitere Ausg.: Druckausg. ISBN 978-149-390-463-1
    Sprache: Englisch
    Fachgebiete: Biologie , Medizin
    RVK:
    RVK:
    RVK:
    Schlagwort(e): Phospholipasen
    URL: Volltext  (lizenzpflichtig)
    URL: Cover
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 5
    Online-Ressource
    Online-Ressource
    New York, NY : Springer New York
    UID:
    gbv_1659082218
    Umfang: Online-Ressource (XV, 295 p. 54 illus., 25 illus. in color, online resource)
    ISBN: 9781493912278
    Serie: Advances in Biochemistry in Health and Disease 11
    Inhalt: The heart has a very high energy demand but very little energy reserves. In order to sustain contractile function, the heart has to continually produce a large amount of ATP. The heart utilizes free fatty acids mainly and carbohydrates to some extent as substrates for making energy, and any change in this energy supply can seriously compromise cardiac function. It has emerged that alterations in cardiac energy metabolism are a major contributor to the development of a number of different forms of heart disease. It is also now known that optimizing energy metabolism in the heart is a viable and important approach to treating various forms of heart disease. Cardiac Energy Metabolism in Health and Disease describes the research advances that have been made in understanding what controls cardiac energy metabolism at molecular, transcriptional, and physiological levels. It also describes how alterations in energy metabolism contribute to the development of heart dysfunction, and how optimization of energy metabolism can be used to treat heart disease. The topics covered include a discussion of the effects of myocardial ischemia, diabetes, obesity, hypertrophy, heart failure, and genetic disorders of mitochondrial oxidative metabolism on cardiac energetics. The treatment of heart disease by optimizing energy metabolism is also discussed, which includes increasing overall energy production as well as increasing the efficiency of energy production and switching energy substrate preference of the heart. This book will be a valuable source of information to graduate students, postdoctoral fellows, and investigators in the field of experimental cardiology as well as biochemists, physiologists, pharmacologists, cardiologists, cardiovascular surgeons and other health professionals
    Anmerkung: Description based upon print version of record , Part 1. Control of Energy Metabolism1. A Primer on Carbohydrate Metabolism in the Heart -- 2. Lipoproteins: A Source of Cardiac Lipids -- 3. Role of Lipoprotein Lipase in Fatty Acid Delivery to the Heart -- 4. Control of Myocardial Fatty Acid Uptake -- 5. Cardiac Energy Metabolism in Heart Failure Associated with Obesity and Diabetes -- 6. Transcriptional Control of Mitochondrial Biogenesis and Maturation -- 7. Relationship between Substrate Metabolism and Cardiac Efficiency -- 8. Acetylation in the Control of Mitochondrial Metabolism and Integrity -- Part 2. Alteration in Energy Metabolism -- 9. Adrenergic Control of Cardiac Fatty Acid Oxidation in Diabetes -- 10. The Myocardial Creatine Kinase System in the Normal, Ischaemic and Failing Heart -- 11. Fuel Metabolism Plasticity in Pathological Cardiac Hypertrophy and Failure -- 12. Defects in Mitochondrial Oxidative Phosphorylation in Hearts Subjected to Ischemia-Reperfusion Injury -- 13. The Role of AMPK in the Control of Cardiac Hypertrophy -- 14. The Role of Incomplete Fatty Acid Oxidation in the Development of Cardiac Insulin Resistance -- Part 3. Optimization of Energy Metabolism -- 15. Metabolic Therapy for the Ischemic Heart -- 16. Inhibition of Fatty Acid Oxidation to Treat Heart Failure in Patients -- 17. Cardiac Metabolic Protection for the Newborn Heart -- 18. Targeting Transcriptional Control of Fatty Acid Oxidation to Treat Heart Disease.
    Weitere Ausg.: ISBN 9781493912261
    Weitere Ausg.: Druckausg. ISBN 978-149-391-226-1
    Sprache: Englisch
    URL: Volltext  (lizenzpflichtig)
    URL: Cover
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 6
    Online-Ressource
    Online-Ressource
    New York, NY : Springer New York
    UID:
    gbv_165320947X
    Umfang: Online-Ressource (XIX, 416 p. 64 illus., 38 illus. in color, online resource)
    ISBN: 9781461493174
    Serie: Advances in Biochemistry in Health and Disease 9
    Inhalt: Diabetes has long been recognized as a disease of high blood sugar, and there has been a continuous search of the exact reason for its development and effective treatment. In 2005, the World Health Organization had estimated that more than 180 million people worldwide suffer from diabetes mellitus and indicated that this figure is likely to double within the next 20 years. Among the 3.8 million deaths each year associated with diabetes, about two thirds are attributable to cardiovascular complications, and diabetes is now considered to be a major metabolic risk factor for the occurrence of heart disease. Diabetic Cardiomyopathy: Biochemical and Molecular Mechanisms is a compilation of review articles devoted to the study on the topic with respect to biochemical and molecular mechanisms of hyperglycaemia. The wide range of areas covered here is of interest to basic research scientists, clinicians and graduate students, who are devoted to study the pathogenesis of diabetes-induced cardiovascular dysfunction. Furthermore, some chapters are directed towards increasing our understanding of novel ways for the prevention/treatment of cardiomyopathy. Twenty five articles in this book are organized in three sections. The first section discusses general aspects of the metabolic derangements in diabetic cardiomyopathy including metabolic alterations and substrate utilization as well as cardiac remodelling in the heart; role of diet in the development of metabolic syndrome in the heart; effect of hyperglycaemia in terms of biochemical and structural alterations in heart. In the second section, several cellular and molecular mechanisms are discussed indicating that diabetic cardiomyopathy is a multifactorial and complex problem. The third section discusses the prevention and treatment of diabetes using appropriate diet, proper supplements including antioxidants, angiotensin inhibitors and some other drugs. All in all, this book discusses the diverse mechanisms of diabetic cardiomyopathy with some information on new therapeutic approaches for finding solutions to prevent or reverse the development of cardiac dysfunction
    Anmerkung: Description based upon print version of record , Cardiac defects in diabetesHormonal imbalance and neuropathy -- Role of oxidative stress -- Role of cation channel defects -- Abnormalities in glucose transport -- Fatty acid utilization -- Sarcolemmal Na+-K+ ATPase -- Sarcolemmal Ca2+-transport -- Sarcoplasmic reticular Ca2+-transport -- Intracellular Ca2+-homeostasis -- Mitochondrial function -- Contractile proteins -- β-adrenoceptor mechanisms -- Protein kinases and signal transduction -- Regulation of phopholipases -- Endothelin defects and cardiac dysfunction -- Metabolic changes in smooth muscles -- Metabolic defects in skeletal muscles -- Metabolic defects in brain -- Role of microangiopathy in heart dysfunction -- Role of nephropathy in heart dysfunction -- Prevention of diabetic-induced cardiac dysfunction -- Molecular targets for the therapy of diabetic cardiomyopathy.
    Weitere Ausg.: ISBN 9781461493167
    Weitere Ausg.: Druckausg. ISBN 978-146-149-316-7
    Sprache: Englisch
    URL: Volltext  (lizenzpflichtig)
    URL: Cover
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 7
    Online-Ressource
    Online-Ressource
    New York, NY : Springer
    UID:
    gbv_1651891176
    Umfang: Online-Ressource (XVII, 465 p. 74 illus., 38 illus. in color, digital)
    ISBN: 9781461452034
    Serie: Advances in Biochemistry in Health and Disease 4
    Inhalt: The processes of adaptation and maladaptation play an important role in the pathogeny of serious cardiovascular diseases, such as hypertension, valvular diseases, congenital heart disease, myocardial infarction and different cardiomyopathies as well as during adaptation to exercise and high altitude hypoxia. This volume incorporates the rapidly developing basic and clinically relevant information on adaptive mechanisms, thereby contributing to the better understanding of possible prevention and therapy of life-threatening cardiovascular diseases. The first section of this volume focuses on developmental aspects of cardiac adaptation, including chapters on comparative and molecular aspects of cardiac development, prenatal and postnatal developments, coronary vascular development, and ontogenetic adaptation to hypoxia, as well as cardiac and arterial adaptation during aging. The second section is devoted to cardiac adaptations to overload on the heart, centered around the mechanisms of cardiac hypertrophy due to pressure overload, volume overload, exercise, gender difference, high altitude, and different pathological situations. The third section of this volume highlights the roles of sympathetic nervous system with respect to α-adrenoceptor and β-adrenoceptor mechanisms in the development of cardiac hypertrophy. Cardiac Adaptations will be of great value to cardiovascular investigators, who will find this book highly useful in their cardiovascular studies for finding solutions in diverse pathological conditions; it will also appeal to students, fellows, scientists, and clinicians interested in cardiovascular abnormalities.
    Anmerkung: Description based upon print version of record , Cardiac Adaptations; Preface; Contents; Contributors; Part I Developmental Aspects of CardiacAdaptation; 1 Comparative Aspects of Cardiac Adaptation; Abstract; 1.1…Introduction; 1.2…Comparative Anatomy; 1.3…Relationship Between Heart and Body Weights in the Animal Kingdom; 1.4…Comparative Aspects of the Myocardial Structure/Blood Supply Relationship; 1.5…The Role of Compact Layer in the Adaptive Growth of the Poikilothermic Heart; 1.6…Cardiac Energy Metabolism in Poikilotherms; 1.7…Cold Adaptation of the Poikilothermic Heart , 1.8…AdaptationAdaptation of the Poikilothermic Heart to Chronic Hypoxia1.9…Conclusions; Acknowledgments; References; 2 Molecular Mechanisms of Cardiac Development; Abstract; 2.1…Introduction to CardiogenesisCardiogenesis; 2.2…Transcriptional Regulators of CardiogenesisCardiogenesis; 2.2.1 Nkx2-5; 2.2.2 MEF2C; 2.2.3 Hand1/Hand2; 2.2.4 Tbx5; 2.2.5 Gata4; 2.2.6 Second Heart Field; 2.2.7 Isl1; 2.2.8 Tbx1; 2.2.9 Hand2; 2.3…Proepicardial Organ and Epicardium; 2.3.1 Tbx18; 2.3.2 Wilms Tumor 1; 2.3.3 Epicardially-Derived Cardiac Endothelial Cells; 2.4…miRNAs and Cardiac Development , 3.4.1 Fetal Guinea Pig Model3.4.2 Genetic Mouse Models; 3.5…Human Fetal Studies; 3.5.1 Hypoplastic Left Heart Syndrome; 3.5.2 Abnormal Hemodynamics in Non-Cardiac Malformations; 3.6…Adaptations in Early Postnatal Period; 3.6.1 Physiological Changes After Birth; 3.6.2 Differences in Reaction to Pressure Overload; 3.6.3 Increased Regenerative Potential; 3.6.4 Implications for Neonatal Cardiac Surgery; 3.7…Conclusions and Perspectives; Conflict of Interests:; References; 4 HypoxiaHypoxia and Mechanical Factors Drive Coronary Vascular DevelopmentDevelopment; Abstract; 4.1…Introduction , 4.2…Hypoxia and Neovascularization: General Concepts4.2.1 HIFs Activate Multiple Vascular Growth Factors; 4.2.2 HypoxiaHypoxia Upregulates VEGFVEGF and VEGFR-1 Signaling; 4.2.3 HypoxiaHypoxia and Vessel Sprouting; 4.3…Hypoxia Signaling During Coronary Development; 4.3.1 Derivation of Coronary Vessel Cells; 4.3.2 In Vivo Studies; 4.3.3 Experimentally-Induced HypoxiaHypoxia in Vitro; 4.3.4 Hypoxic Induces Embryonic Stem Cells; 4.3.5 Fetal Coronary DevelopmentDevelopment: Responses to Hypoxemia; 4.3.6 HypoxiaHypoxia and Blood Flow Induce Coronary Growth , 4.3.7 Nitric Oxide and High Coronary Blood Flow , Comparative Aspects of Cardiac Adaptation -- Molecular Mechanisms in Cardiac Development -- Prenatal Adaptation to Overload -- Hypoxia and Mechanical Factors Drive Coronary Vascular Development -- Cardiac Metabolic Adaptation During Postnatal Development -- Ontogenetic Adaptation to Chronic Hypoxia -- Heart and Arterial Aging -- Differences in Concentric Cardiac Hypertrophy and Eccentric Hypertrophy -- Cardiac Adaptation to Volume Overload -- Functional Adaptation during the Development of Cardiac Hypertrophy and Heart Failure in Females -- Impact of Gender and Exercise on Cardiac Adaptation to Pathological Situations -- Cardiopulmonary Adaptation to High Altitude -- Cardiac Hypertrophy in Hypertension -- Exercise Training and Adverse Cardiac Remodeling and Dysfunction in Mice -- The Athlete’s Heart -- Role of β - Adrenoceptor/Adenylyl Cyclase System in Cardiac Hypertrophy -- Role of Phospholipase C in the α1 - Adrenoceptor Mediated Cardiac Hypertrophy -- Maladaptive Cardiac Remodeling: Signal-dependent Regulation of the Fibrotic Gene Program by CLP-1 in the Hypertrophic Heart -- Role of Sirtuins in Regulation of Cardiac Adaptation Associated with Hypertrophy -- Adaptation of Cardiac and Skeletal Muscle Mitochondria to Endurance Training: Implications for Cardiac Protection -- Adenosine as an Endogenous Adaptive Cardiac Antihypertrophic and Antiremodelling Factor -- Myocardial Adaptation and Autophagy -- Modulatory Role of VEGF in Angiogenesis for Cell Survival -- The Role of CaM Kinase II in Cardiac Function in Health and Disease..
    Weitere Ausg.: ISBN 9781461452027
    Weitere Ausg.: Buchausg. u.d.T. ISBN 978-1-461-45202-7
    Sprache: Englisch
    URL: Volltext  (lizenzpflichtig)
    URL: Cover
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 8
    Online-Ressource
    Online-Ressource
    New York, NY : Springer New York
    UID:
    gbv_1653172444
    Umfang: Online-Ressource (XV, 403 p. 84 illus., 37 illus. in color, online resource)
    ISBN: 9781461492337
    Serie: Advances in Biochemistry in Health and Disease 7
    Inhalt: Proteases form one of the largest and most diverse families of enzymes known. Once considered primarily as “enzymes of digestion,” it is now clear that proteases are involved in every aspect of cellular function. Members of the diverse families of proteases act to promote cellular proteolysis found in nature, and their deregulation may result in different pathophysiological conditions, such as tumor progression, vascular remodeling, atherosclerotic plaque progression, ulcer, rheumatoid arthritis, and Alzheimer’s disease. Many micro-organisms require proteases for replication or use proteases as virulence factors, which have facilitated the development of protease-targeted therapies for a variety of parasitic diseases. Proteases in Health and Disease represents a comprehensive overview of the fascinating field of proteases by various renowned experts, and focuses on the recently elucidated functions of complex proteolytic systems in physiology and pathophysiology. Part A, Molecular and Biochemical Aspects of Proteases, illustrates some of the major proteases, such as calpains, matrix metalloproteases, fibrinolytic serine proteases, and aspartic proteases, which play a significant role in a variety of pathologies and may be a target for therapy either by their up regulation or down regulation. Part B, Involvement of Proteases in Diseases Processes, deals with the functional roles of the individual proteases in the progression of diseases such as cardiovascular and inflammatory lung disease, malaria, cholera, autism spectrum disorder, hepatitis, and ischemia-reperfusion injury induced cardiac diseases. With this multi-disciplinary scope, the book bridges the gap between fundamental research and biomedical and pharmaceutical applications, making this a thought-provoking reading for basic and applied scientists engaged in biomedical research. About the Editors: Dr. Sajal Chakraborti is a Senior Professor of Biochemistry at the University of Kalyani, West Bengal, India. His research covers the role of proteases in regulating pulmonary vascular tone under oxidant- and calcium-signaling phenomena. He has been engaged in teaching and research in biochemistry for the past 35 years. Dr. Naranjan Dhalla is a Distinguished Professor at the University of Manitoba, Winnipeg, Canada. His expertise includes the subcellular and molecular basis of heart function in health and disease. He has been engaged in multidisciplinary research and education for promoting th ...
    Anmerkung: Description based upon print version of record , Part A: Molecular and Biochemical Aspects of Proteases1. An Overview of Endoplasmic Reticulum Calpain System -- 2. Mitochondrial Calpains: Who, What, Where, When and Why? -- 3. Role of Calpains in Calmodulin Regulated Systems -- 4. Exercise and Matrix Metalloproteases: A Brief Overview -- 5. Regulation of Chondrocyte Matrix Metalloproteinase Gene Expression -- 6. Microbial Source of Fibrinolytic Protease and Its Biotechnological Potential -- 7. Aspartic Proteolytic Inhibitors Induce Cellular and Biochemical Alterations in Fungal Cells -- 8. Cysteine Proteases of Human Malaria Parasites -- 9. Proteases as Virulence Factors in Leishmania: Focus on Serine Proteases as Possible Therapeutic Targets -- 10. An Updated Inventory on Properties, Pathophysiology and Therapeutic Potential of Snake Venom Thrombin-like Proteases -- 11. Macrocyclic Protease Inhibitors Constrained into a β-Strand Geometry -- Part B: Involvement of Proteases in Disease Processes -- 12. Regulation of MT1-MMP Activation and Its Relevance to Disease Processes -- 13. Role of Proteases During Intra-erythrocytic Developmental Cycle of Human Malaria Parasite Plasmodium falciparum -- 14. Proteases in Vibrio cholerae and Their Role in Pathogenesis -- 15. ADAMTS13: The von Willebrand Factor Cleaving Protease and Its Role in Thrombotic Thrombocytopenic Purpura -- 16. Role of Proteases and Their Tissue Inhibitors in Pregnancy Outcome -- 17. Matrix Metalloproteinases in Bone Health and Disease -- 18. Escalated Expression of Matrix Metalloproteinases in Osteoarthritis -- 19. Role of Proteases in Autism Spectrum Disorder -- 20. Role of Proteases in the Management of Hepatitis C Virus -- 21. Role of Protease in Inflammatory Lung Diseases -- 22. Involvement of Some Proteolytic Enzymes in Cardiac Dysfunction Due to Ischemia-Reperfusion Injury.
    Weitere Ausg.: ISBN 9781461492320
    Weitere Ausg.: Druckausg. ISBN 978-146-149-232-0
    Sprache: Englisch
    URL: Volltext  (lizenzpflichtig)
    URL: Cover
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 9
    UID:
    gbv_848730127
    ISSN: 1205-7541
    In: Canadian journal of physiology and pharmacology, Ottawa, Ont. : NRC Research Press, 1964, 92(2014), 5, Seite 5-6, 1205-7541
    In: volume:92
    In: year:2014
    In: number:5
    In: pages:5-6
    Sprache: Englisch
    Mehr zum Autor: Maisch, Bernhard
    Mehr zum Autor: Werdan, Karl 1947-
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie auf den KOBV Seiten zum Datenschutz